Cambridge Investment Research Advisors’s Aterian ATER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,590
Closed -$9K 3143
2023
Q2
$9K Sell
1,590
-2,690
-63% -$20.9K ﹤0.01% 3152
2023
Q1
$44K Sell
4,280
-86
-2% -$1.15K ﹤0.01% 3049
2022
Q4
$40K Buy
4,366
+386
+10% +$4.84K ﹤0.01% 3004
2022
Q3
$59K Sell
3,980
-34
-0.8% -$990 ﹤0.01% 2924
2022
Q2
$104K Sell
4,014
-767
-16% -$33.9K ﹤0.01% 2861
2022
Q1
$139K Buy
4,781
+558
+13% +$20.4K ﹤0.01% 2960
2021
Q4
$208K Sell
4,223
-930
-18% -$68.8K ﹤0.01% 2860
2021
Q3
$670K Buy
5,153
+3,847
+295% +$427K ﹤0.01% 1819
2021
Q2
$229K Sell
1,306
-70
-5% -$16.4K ﹤0.01% 2702
2021
Q1
$487K Buy
1,376
+83
+6% +$32K ﹤0.01% 1926
2020
Q4
$267K Hold
1,293
﹤0.01% 2242
2020
Q3
$128K Hold
1,293
﹤0.01% 2350
2020
Q2
$85K Hold
1,293
﹤0.01% 2333
2020
Q1
$26K Buy
+1,293
New +$63.5K ﹤0.01% 2227

Other funds holding ATER

Cambridge Investment Research Advisors's ATER Position: Q3 2023 in Review

Cambridge Investment Research Advisors sold out of Aterian (ATER) in Q3 2023, closing a stake of 1,590 shares — an estimated $9K sold.

Cambridge Investment Research Advisors first reported a position in ATER in Q1 2020 and held it in 14 quarters. The position peaked at $670K in Q3 2021. 41 funds tracked by Wall St. Rank hold ATER as of Q3 2023.

  • Cambridge Investment Research Advisors reported no remaining Aterian position as of Q3 2023 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 1,590 Aterian shares in Q3 2023, an estimated $9K.
  • Cambridge Investment Research Advisors first reported a position in Aterian in Q1 2020 and held it in 14 quarters.
  • Cambridge Investment Research Advisors's Aterian position peaked at $670K in Q3 2021.
  • 41 funds tracked by Wall St. Rank held Aterian as of Q3 2023.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.